EDGEWELL PERSONAL CARE Co EPC

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived NYSE

Edgewell Personal Care Company, and its subsidiaries, is one of the world's largest manufacturers and marketers of personal care products in the Wet Shave, Sun and Skin Care, and Feminine Care segments. With operations in approximately 20 countries, our products are widely available in more than 50 countries.

We were incorporated in the State of Missouri on September 23, 1999 and, prior to April 2000, were a wholly-owned subsidiary of Ralston Purina Company. On April 1, 2000, all of the outstanding shares of our common stock were distributed to shareholders of Ralston Purina Company and we became an independent publicly-owned company. During the years that followed, we implemented a strategy of acquiring several personal care brands, which created the foundation for the company we are today.

Last close 28.06 2026-10-23
Market cap $1.29B 2026-06-30 share count
52-week range 15.72 - 29.95

Valuation FY2025 figures against the last close

P/S0.6x
P/E52.9x
P/FCF31.2x
EV/EBITDA13.2x
Dividend yield2.3%
Diluted EPS0.53

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • International
Revenue by geography, 2 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 1.2B (54.2%) 54% United States International, FY2025: 1B (45.8%) 46% International FY2024 United States, FY2024: 1.3B (56.0%) 56% International, FY2024: 991.9M (44.0%) 44% FY2023 United States, FY2023: 1.3B (58.9%) 59% International, FY2023: 925.5M (41.1%) 41%
Region FY2025FY2024FY2023
United States $1.20B $1.26B $1.33B
International $1.02B $991.9M $925.5M

As the company reported it, from the “Segment and Geographical Data (Schedule of Geographical Segment Information) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Revenue by segment

  • Wet Shave
  • Sun and Skin Care
  • Feminine Care
Revenue by segment, 3 categories over 3 years. The same figures are in the table below. FY2025 Wet Shave, FY2025: 1.2B (54.8%) 55% Wet Shave Sun and Skin Care, FY2025: 743.1M (33.4%) 33% Sun and Skin Care Feminine Care, FY2025: 261.5M (11.8%) 12% Feminine Care FY2024 Wet Shave, FY2024: 1.2B (54.5%) 55% Sun and Skin Care, FY2024: 740.8M (32.9%) 33% Feminine Care, FY2024: 283.6M (12.6%) 13% FY2023 Wet Shave, FY2023: 1.2B (54.7%) 55% Sun and Skin Care, FY2023: 705.5M (31.3%) 31% Feminine Care, FY2023: 315.2M (14.0%) 14%
Segment FY2025FY2024FY2023
Wet Shave $1.22B $1.23B $1.23B
Sun and Skin Care $743.1M $740.8M $705.5M
Feminine Care $261.5M $283.6M $315.2M

As the company reported it, from the “Segment and Geographical Data (Schedule of Segment Disclosures) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.22B$2.25B$2.25B$2.17B$2.09B$1.95B$2.14B$2.23B$2.30B$2.36B
Cost of revenue $1.30B$1.30B$1.31B$1.29B$1.14B$1.07B$1.17B$1.20B$1.17B$1.20B
Gross profit $924.9M$955.7M$940.8M$880.5M$951.2M$880.9M$966.6M$1.03B$1.13B$1.16B
R&D $57.6M$58.4M$58.5M$55.5M$57.8M$55.3M$53.5M$61.1M$67.6M$71.9M
SG&A $425.0M$430.1M$409.6M———————
Operating income $96.6M$199.3M$227.0M$182.3M$239.9M$176.0M$243.8M———
Interest expense $73.2M$76.5M$78.5M$71.4M$67.9M$61.2M$62.6M$68.0M$69.2M$71.8M
Pre-tax income $23.6M$120.9M$147.7M$124.1M$147.1M$87.3M-$390.3M$163.8M-$52.9M$219.9M
Income tax $1.8M$22.3M$33.0M$24.6M$29.3M$19.7M$18.1M$60.5M$58.6M$41.2M
Net income $25.4M$98.6M$114.7M$99.5M$117.8M$67.6M-$372.2M$103.3M$5.7M$178.7M
EPS, basic 0.531.982.241.872.171.25-6.881.900.103.02
EPS, diluted 0.531.972.211.852.131.24-6.881.900.102.99
Shares, diluted (wtd. avg.) 47.6M50.1M51.8M53.6M55.2M54.6M54.1M54.5M57.5M59.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $225.7M$209.1M$216.4M$188.7M$479.2M$364.7M$341.6M$266.4M$502.9M$738.9M
Receivables $137.8M$109.4M$106.2M$136.9M$150.7M$158.8M$205.6M$226.5M$224.1M$260.7M
Inventory $484.7M$477.3M$492.4M$449.3M$345.7M$314.1M$357.2M$329.5M$333.5M$309.2M
Total current assets $995.5M$936.0M$962.4M$942.2M$1.14B$983.6M$1.04B$951.2M$1.19B$1.45B
Property, plant and equipment $369.3M$349.1M$337.9M$345.5M$362.6M$370.9M$396.0M$424.1M$453.4M$486.1M
Goodwill $1.29B$1.34B$1.33B$1.32B$1.16B$1.16B$1.03B$1.45B$1.45B$1.42B
Other intangibles $921.3M$948.5M$973.8M$996.6M$906.4M$928.1M$912.9M$1.10B$1.07B$1.39B
Total assets $3.76B$3.73B$3.74B$3.71B$3.67B$3.54B$3.42B$3.95B$4.19B$4.77B
Accounts payable $219.7M$219.3M$194.4M$228.8M$209.5M$181.9M$222.8M$238.4M$223.6M$196.5M
Short-term debt ———$0$0$0$117.0M$184.9M$0$281.8M
Total current liabilities $565.5M$563.6M$523.4M$539.5M$536.8M$510.5M$659.6M$717.0M$524.4M$868.2M
Long-term debt $1.38B$1.27B$1.36B$1.39B$1.23B$1.24B$1.10B$1.10B$1.53B$1.54B
Total liabilities $2.20B$2.15B$2.20B$2.25B$2.09B$2.11B$2.12B$2.21B$2.45B$2.94B
Retained earnings $1.09B$1.09B$1.02B$939.1M$865.7M$782.4M$714.8M$1.08B$952.9M$946.0M
Total equity $1.55B$1.58B$1.54B$1.47B$1.59B$1.44B$1.30B$1.74B$1.74B$1.83B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $118.4M-$231.0M-$216.1M$102.0M$229.0M$232.6M$190.6M$259.4M$313.6M$186.8M
Depreciation and amortisation $88.8M$88.0M$91.4M$89.9M$87.1M$88.8M$93.8M$97.6M$94.4M$92.6M
Stock-based compensation $24.5M$26.5M$27.5M$23.8M$27.3M$19.2M$17.8M$17.0M$22.2M$25.6M
Capital expenditure $77.0M$56.5M$49.5M$56.4M$56.8M$47.7M$58.0M$62.0M$69.0M$69.5M
Investing cash flow -$72.9M-$62.4M-$50.5M-$355.4M-$48.7M-$196.4M-$45.5M-$118.8M-$84.6M-$69.5M
Financing cash flow -$30.0M-$179.4M-$146.5M-$17.6M-$65.4M-$18.7M-$63.8M-$379.6M-$478.0M-$93.4M
Dividends paid $29.3M$30.7M$31.5M$32.6M$25.6M$0$0—$0$0
Buybacks $90.2M$58.5M$75.2M$125.3M$9.2M$0$0$124.4M$165.4M$196.6M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-25-052765.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B 0 1B 2B 3B Revenue, FY2016: 2.4B Gross profit, FY2016: 1.2B Net income, FY2016: 178.7M Revenue, FY2017: 2.3B Gross profit, FY2017: 1.1B Net income, FY2017: 5.7M Revenue, FY2018: 2.2B Gross profit, FY2018: 1B Net income, FY2018: 103.3M Revenue, FY2019: 2.1B Gross profit, FY2019: 966.6M Net income, FY2019: -372.2M Revenue, FY2020: 1.9B Gross profit, FY2020: 880.9M Net income, FY2020: 67.6M Revenue, FY2021: 2.1B Gross profit, FY2021: 951.2M Net income, FY2021: 117.8M Revenue, FY2022: 2.2B Gross profit, FY2022: 880.5M Net income, FY2022: 99.5M Revenue, FY2023: 2.3B Gross profit, FY2023: 940.8M Net income, FY2023: 114.7M Revenue, FY2024: 2.3B Gross profit, FY2024: 955.7M Net income, FY2024: 98.6M Revenue, FY2025: 2.2B Gross profit, FY2025: 924.9M Net income, FY2025: 25.4M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.36B $2.30B $2.23B $2.14B $1.95B $2.09B $2.17B $2.25B $2.25B $2.22B
Gross profit $1.16B $1.13B $1.03B $966.6M $880.9M $951.2M $880.5M $940.8M $955.7M $924.9M
Net income $178.7M $5.7M $103.3M -$372.2M $67.6M $117.8M $99.5M $114.7M $98.6M $25.4M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Item 7.01
  • Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $39.37B 217.3x 5.0%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
IPAR INTERPARFUMS INC $3.69B 22.0x 2.5%
COTY COTY INC. $2.84B — -1.5%
WALD Waldencast plc $100.3M — -0.7%
SLSN SOLESENCE, INC. $56.5M 40.0x 18.6%